These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 3220097)

  • 1. Pharmacokinetics of bolus intravenous and oral doses of L-carnitine in healthy subjects.
    Harper P; Elwin CE; Cederblad G
    Eur J Clin Pharmacol; 1988; 35(1):69-75. PubMed ID: 3220097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of intravenous and oral bolus doses of L-carnitine in healthy subjects.
    Harper P; Elwin CE; Cederblad G
    Eur J Clin Pharmacol; 1988; 35(5):555-62. PubMed ID: 3234464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of L-carnitine pharmacokinetics with and without baseline correction following administration of single 20-mg/kg intravenous dose.
    Sahajwalla CG; Helton ED; Purich ED; Hoppel CL; Cabana BE
    J Pharm Sci; 1995 May; 84(5):634-9. PubMed ID: 7658357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of propionyl-L-carnitine in humans: evidence for saturable tubular reabsorption.
    Pace S; Longo A; Toon S; Rolan P; Evans AM
    Br J Clin Pharmacol; 2000 Nov; 50(5):441-8. PubMed ID: 11069438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetics, pharmacokinetics, and regulation of L-carnitine and acetyl-L-carnitine metabolism.
    Rebouche CJ
    Ann N Y Acad Sci; 2004 Nov; 1033():30-41. PubMed ID: 15591001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of pharmacokinetics of L-carnitine, acetyl-L-carnitine and propionyl-L-carnitine after single oral administration of L-carnitine in healthy volunteers.
    Cao Y; Wang YX; Liu CJ; Wang LX; Han ZW; Wang CB
    Clin Invest Med; 2009 Feb; 32(1):E13-9. PubMed ID: 19178874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of L-carnitine.
    Evans AM; Fornasini G
    Clin Pharmacokinet; 2003; 42(11):941-67. PubMed ID: 12908852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma and urine pharmacokinetics of free and of short-chain carnitine after administration of carnitine in man.
    Segre G; Bianchi E; Corsi M; D'Iddio S; Ghirardi O; Maccari F
    Arzneimittelforschung; 1988 Dec; 38(12):1830-4. PubMed ID: 3245856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fractional absorption of L-carnitine after oral administration in rats: evaluation of absorption site and dose dependency.
    Matsuda K; Yuasa H; Watanabe J
    Biol Pharm Bull; 1998 Jul; 21(7):752-5. PubMed ID: 9703262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of ciprofloxacin after intravenous and increasing oral doses.
    Bergan T; Thorsteinsson SB; Kolstad IM; Johnsen S
    Eur J Clin Microbiol; 1986 Apr; 5(2):187-92. PubMed ID: 2941278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral and intravenous pharmacokinetics of milrinone in human volunteers.
    Stroshane RM; Koss RF; Biddlecome CE; Luczkowec C; Edelson J
    J Pharm Sci; 1984 Oct; 73(10):1438-41. PubMed ID: 6502494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetics of intravenously administered carnitine in haemodialysed children.
    Glöggler A; Bulla M; Fürst P
    J Pharm Biomed Anal; 1990; 8(5):411-4. PubMed ID: 2081201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolism and disposition of intravenously administered acetyl-L-carnitine in healthy volunteers.
    Marzo A; Arrigoni Martelli E; Urso R; Rocchetti M; Rizza V; Kelly JG
    Eur J Clin Pharmacol; 1989; 37(1):59-63. PubMed ID: 2591464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of ciprofloxacin: intravenous and increasing oral doses.
    Bergan T; Thorsteinsson SB; Solberg R; Bjornskau L; Kolstad IM; Johnsen S
    Am J Med; 1987 Apr; 82(4A):97-102. PubMed ID: 3578334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of dexloxiglumide after administration of single and repeat oral escalating doses in healthy young males.
    Persiani S; D'Amato M; Makovec F; Tavares IA; Bishai PM; Rovati LC
    Int J Clin Pharmacol Ther; 2002 May; 40(5):198-206. PubMed ID: 12051571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral bioavailability and intravenous pharmacokinetics of amrinone in humans.
    Park GB; Kershner RP; Angellotti J; Williams RL; Benet LZ; Edelson J
    J Pharm Sci; 1983 Jul; 72(7):817-9. PubMed ID: 6886991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disposition and metabolite kinetics of oral L-carnitine in humans.
    Bain MA; Milne RW; Evans AM
    J Clin Pharmacol; 2006 Oct; 46(10):1163-70. PubMed ID: 16988205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of azapropazone following single oral and intravenous doses.
    Breuing KH; Gilfrich HJ; Meinertz T; Jähnchen E
    Arzneimittelforschung; 1979; 29(6):971-2. PubMed ID: 582795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of oral and intravenous omeprazole in patients with the Zollinger-Ellison syndrome.
    Vinayek R; Amantea MA; Maton PN; Frucht H; Gardner JD; Jensen RT
    Gastroenterology; 1991 Jul; 101(1):138-47. PubMed ID: 2044903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of the new benzodiazepine antagonist Ro 15-1788 in man following intravenous and oral administration.
    Roncari G; Ziegler WH; Guentert TW
    Br J Clin Pharmacol; 1986 Oct; 22(4):421-8. PubMed ID: 3094572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.